ENZ News and Press, Enzo Biochem Inc.

2024-07-17 00:49:37 ET Summary Enzo Biochem shareholders frustrated with lack of capital returns following Clinical Labs sale to Labcorp Holdings. Stock trading near historic lows, but potential for attractive returns with simplified Life Sciences division and strong CEO incentive...

2024-06-13 16:52:49 ET More on Enzo Biochem Financial information for Enzo Biochem Read the full article on Seeking Alpha For further details see: Enzo Biochem Non-GAAP EPS of -$0.03, revenue of $8.02M

SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...

2024-06-09 08:01:00 ET More on companies reporting earnings during the week FuelCell Energy: Consider Potential Q2 Results Miss And Korean Market Opportunities Oracle: Strong EPS Growth Expected In 2025 And 2026, Watching Q4 Margins (Rating Upgrade) Broadcom: It's To...

2024-05-02 09:00:00 ET Summary For the first quarter, 1 Main Capital returned (5.1)% net, compared to 10.6% for the S&P 500 and 5.2% for the Russell 2000. At quarter-end, the Fund’s top five positions accounted for slightly more than 70% of capital. While I don ...

2024-03-13 16:54:00 ET More on Enzo Biochem Financial information for Enzo Biochem Read the full article on Seeking Alpha For further details see: Enzo Biochem Non-GAAP EPS of $0.00, revenue of $8.55M

FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. Second Quarter Highlights The Company's Life Science division's...

FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments. Summary of the Fis...

2024-02-01 03:21:00 ET Summary Laughing Water Capital is a concentrated, long biased investment partnership open to accredited investors. Our interests are fully aligned with our partners as nearly all of our personal wealth is invested in our strategy. For Q4 2023, Class A intere...

FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023. First Quarter Highlights The Company's Life Sciences division's fir...